IO Biotech, Inc.

8-K Bankruptcy or receivership; Triggering event accelerating an obligation; Director or officer change; Other events Mar 31, 2026 8-K Delisting notice or listing-rule failure Feb 13, 2026 8-K Exit or disposal costs; Director or officer change; Other events Jan 30, 2026 8-K Other events Jan 21, 2026 8-K Delisting notice or listing-rule failure Dec 19, 2025 8-K Director or officer change Nov 21, 2025 8-K Regulation FD disclosure Nov 18, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Results of operations (earnings release) Nov 14, 2025 8-K Exit or disposal costs; Regulation FD disclosure; Other events Sep 29, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Aug 11, 2025 8-K Unregistered sale of equity; Other events Jun 27, 2025 8-K Director or officer change Jun 20, 2025 8-K Shareholder vote results Jun 9, 2025 8-K Other events Jun 4, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 8-K Unregistered sale of equity; Other events Apr 30, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 4, 2025 8-K Delisting notice or listing-rule failure Dec 27, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Regulation FD disclosure Dec 20, 2024 8-K Amended charter or bylaws Dec 16, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Regulation FD disclosure; Other events Aug 30, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release) Aug 13, 2024 8-K Shareholder vote results Jun 11, 2024 8-K Results of operations (earnings release) May 14, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Director or officer change Apr 26, 2024 10-K/A Fiscal year ended 2023-12-31 Mar 22, 2024 10-K Fiscal year ended 2023-12-31 Mar 5, 2024 8-K Results of operations (earnings release) Mar 5, 2024 8-K Regulation FD disclosure Jan 8, 2024 10-Q Quarter ended 2023-09-30 Nov 13, 2023 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Nov 13, 2023